Home
Centre for the Study of the Sciences and the Humanities
Research centre

Centre for Cancer Biomarkers - ELSA research

Researchers at SVT are leading the research group on ELSA (Ethical, Legal and Social Aspects of new technology) at the Centre for Cancer Biomarkers (CCBIO) at UiB.

cells in mikroskop

Main content

Centre for Cancer Biomarkers (CCBIO) is a Centre of Excellence at the Faculty of Medicine and Dentistry, University of Bergen.
The center is working on new cancer biomarkers and targeted therapy, and has particular focus on mechanisms that show how cancer cells are affected by the microenvironment in the tumors, and what significance this has for cancer proliferation and poor prognosis.

CCBIO’s research group on ELSA (Ethical, Legal and Social Aspects of new technology) is led by a SVT team consisting of professor Roger Strand and researcher Anne Blanchard.

CCBIO PhD course

Since 2015, Blanchard and Strand have taught the PhD course CCBIO903 - Cancer Research - Ethical, Economic and Social Aspects. It has provided young cancer researchers with an opportunity to learn about and think through the many complex issues surrounding the developments in cancer research and cancer care.

In April 2018, their work with this course was presented at the 2nd HEIRRI conference in Vienna. The University of Bergen (and specifically the Centre for the Study of the Sciences and the Humanities) was a partner of HEIRRI, "Higher Education Institutions and Responsible Research and Innovation", a 3-year Horizon 2020 project that developed didactic principles and materials for teaching RRI. In Blanchard and Strand's poster contribution, they highlighted the underlying double purpose of CCBIO903: To educate tomorrow's leaders in cancer research and cancer care, but in this way also transform the research culture and practice of CCBIO towards RRI. See the poster from the conference to the right.

More about SVT's CCBIO work

Tilknyttet innhold